AERO-002 (60 mcg) clinical trials

Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

This study looks at a new inhaled medicine for people with COPD, called AERO-007. It's a combination of two drugs, given through a nebuliser. Researchers want to see how the body handles this new medicine, especially how much gets into the bloodstream compared to other similar treatments.